October 26, 2020
Dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy
(LOS ANGELES) – Breast cancer is the most commonly occurring cancer for women around the world, and much effort has been spent in the development of therapies to treat this disease. Among these treatments, chemotherapy has been shown to be among the most effective methods; however, the drugs used in these therapies can have adverse side effects, the most serious of which is toxicity to the heart. In addition to tissue damage to the heart, chemotherapeutic breast cancer drugs can also affect the heart’s pumping ability or result in clinical heart failure.